openPR Logo
Press release

Fibromyalgia Treatment Market Global Industry Insights 2018-2026

08-09-2018 03:33 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Fibromyalgia Treatment Market Global Industry Insights

Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms can be gradually accumulated with the time or it can be done by some external factors. Fibromyalgia treatments include therapy, medications, regular aerobic exercise, stress reduction, and others. Furthermore, for treatment of Fibromyalgia antidepressants or pain medication are prescribed to treat depression, anxiety, pain, and fatigue.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1691

Fibromyalgia Treatment Market: Market Dynamics

Increasing prevalence of Fibromyalgia is expected to augment market growth. According to National Fibromyalgia and Chronic Pain Association, 2014, an estimated 210 million people in 2015, were affected with fibromyalgia syndrome, accounting for 2-4% of the total world population. Moreover, growth of the market is driven by increasing clinical trials by the manufacturers and research organizations and launch of novel diagnostics in order to reduce the burden of the disease with early and accurate disease diagnosis. For instance, in 2013, Innovative Med Concepts, LLC initiated the clinical trial for the drug candidate IMC-1, for the treatment of patients with fibromyalgia. Also, in March 2018, IQuity, a data science company launched a new blood test called Isolate Fibromyalgia, which uses RNA gene expression analysis to detect fibromyalgia, thus aiding in efficient diagnostics, which can provide early medical intervention.

Furthermore, various organizations are supporting research and development and providing accessible, affordable, and appropriate treatment which is expected to augment the market growth over the forecast period. For instance, a non-profit organization named National Fibromyalgia and Chronic Pain Association (NFMCPA) aims to build a united patient and health care community educate and execute advocacy programs regarding access to care, research, diagnosis and treatment for people suffering with chronic pain from fibromyalgia and overlapping conditions.

However, the difficulty to diagnose fibromyalgia since most of the symptoms are associated with other diseases, reduces the rate of diagnosis of patients with fibromyalgia, thereby hindering the growth of fibromyalgia treatment market.

Fibromyalgia Treatment Market: Regional Dynamics

Regional segmentation of the global fibromyalgia treatment market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global fibromyalgia treatment market, owing to increasing incidence of fibromyalgia and to curb the economic burden associated with the disease in the U.S. According to the National Fibromyalgia Association, 2015, fibromyalgia affects an estimated 10 million people in the U.S. Moreover, according to the Community Pain Center, Fibromyalgia is responsible for a decrease in productivity by 1-2%, resulting in direct and indirect expenditures of US$ 15 billion in the U.S., thus impelling the organizations and manufacturers to launch efficient therapies, which in turn is expected to bolster the fibromyalgia treatment market in the region.

The Fibromyalgia treatment market in Europe is expected to gain significant traction, owing to the presence of support groups providing online support combined with fund raising activities to make treatments available for the patients. For instance, the Fibromyalgia Action UK improves the lives of people with fibromyalgia by increasing awareness of the condition throughout the country, thereby improving awareness and access to treatments for fibromyalgia. Also, the UK Fibromyalgia, a member of Disability Rights UK, is focused on spreading awareness regarding Fibromyalgia condition through magazines and social media accounts, as well as encourages National Health Society (NHS) and private organizations to invest in new research projects.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1691

Fibromyalgia Treatment Market: Competitive Landscape

The key players in Fibromyalgia treatment market are focusing on developing innovative solutions to treat generalized pain associated with fibromyalgia. For instance, in October 2017, Avacen Medical launched an Avacen 100 Class II, which provides provide non-invasive, rapid whole-body treatment, using a single point of contact. Avacen treatment method is a novel concept in the chronic pain treatment that safely and non-invasively infuses heat into the circulatory system to generate muscular relaxation, thus providing an ideal drug-free and safe alternative for pain relief.

Key players operating in the global fibromyalgia treatment market include Eli Lilly and Company, Pfizer Inc., Merck & Co., Johnson & Johnson, GlaxoSmithKline Plc., Novartis AG, Sanofi S.A., AstraZeneca, and Allergan Plc.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia Treatment Market Global Industry Insights 2018-2026 here

News-ID: 1171310 • Views: 346

More Releases from Coherent Market Insights

French Fries Market Analysis and Value Forecast Snapshot by End-use Industry 202 …
French Fries Market report provide pin-point analysis of the French Fries industry: Capacity, Production, Value, Consumption and Status (2014-2019) and Six- Year Forecast (2020-2027). Bedsides French Fries market research report enriched on worldwide competition by topmost prime manufactures (McCain, JR Simplot, Lamb-Weston, Aviko, Farm Frites, Ore-Ida, Cascadian Farm Organic, Alexia Foods, Trader Joe's Fan, Checkers & Rally's, and Arby's IP Holder among others.) which providing information such as Company Profiles,
Melon Seeds Market See Incredible Growth and Forecast 2020-2027 | Bayer Group, B …
Melon Seeds Market report provide pin-point analysis of the Melon Seeds industry: Capacity, Production, Value, Consumption and Status (2014-2019) and Six- Year Forecast (2020-2027). Bedsides Melon Seeds market research report enriched on worldwide competition by topmost prime manufactures (Bayer Group, BASF SE, Groupe Limagrain, Syngenta, AG, Advanta Seeds, Sakata Seed Corporation, Semillas Fit, SA, Yksel Tohum A.?, Johnny's Selected Seeds, and Rijk Zwaan Zaadteelt en Zaadhandel B.V.) which providing information
Potato Chips Market Poised to Garner Maximum Revenues During 2020-2027 | Kiwi Fo …
Potato Chips Market report provide pin-point analysis of the Potato Chips industry: Capacity, Production, Value, Consumption and Status (2014-2019) and Six- Year Forecast (2020-2027). Bedsides Potato Chips market research report enriched on worldwide competition by topmost prime manufactures (Kiwi Food, Balaji Wafers Pvt Ltd., Lay's, Bikaji Snacks, Pringles, Ruffles, PepsiCo, The Kellogg Company, Herr Foods Inc., Kettle Foods, Inc., and Calbee, Inc.) which providing information such as Company Profiles, Product
Aluminum Market Expected to Witness a Sustainable Growth by 2027
Aluminum Market report provide pin-point analysis of the Aluminum industry: Capacity, Production, Value, Consumption and Status (2014-2019) and Six- Year Forecast (2020-2027). Bedsides Aluminum market research report enriched on worldwide competition by topmost prime manufactures (Rio Tinto Plc, Norsk Hydro ASA, UC RUSAL, Alcoa Inc., China Hongqiao Group Ltd., Aluminum Corporation of China Limited, Emirates Global Aluminum PJSC, Noranda Aluminum Holding Corporation, Aditya Birla Management Corporation Pvt. Ltd., China Power

All 5 Releases


More Releases for Fibromyalgia

Anticonvulsant Market for Fibromyalgia Competitive Analysis and Forecast 2017-20 …
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-20 …
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms
Fibromyalgia Treatment Market Global Opportunity Analysis, 2018-2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1691 An individual with fibromyalgia can also have symptoms such
Anticonvulsant Market for Fibromyalgia Optimistic Opportunities 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market | SWOT Analysis of Major Market Segments
Fibromyalgia disorder is characterized by musculoskeletal pain along with characteristics of fatigue, sleep disorders, memory and mood issues, irritable bowel syndrome, headaches, depression, and anxiety. It is believed that fibromyalgia alters the pain sensations mechanism controlled by the brain. An individual with fibromyalgia also can have symptoms such as tension headaches, migraine, temporomandibular joint (TMJ) disorders. Symptoms of fibromyalgia can be gradually accumulated with the time, or it can be
Fibromyalgia Therapeutics - Pipeline Analysis 2018
Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain